Anti-CTLA-4 antibody
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Anti-CTLA-4 antibody, covering 2016-10-17 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer [Phase 2]